{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:40:15Z","timestamp":1743388815478,"version":"3.40.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Vanderbilt-Meharry James Puckette Carter Scholarship Program Burroughs Welcome"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10549-025-07621-w","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:15:35Z","timestamp":1739175335000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lumpectomy surgery for large ductal carcinoma in situ"],"prefix":"10.1007","volume":"211","author":[{"given":"Daniela Bresciani","family":"Padilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Sutherland","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene L.","family":"Wapnir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"7621_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-015-0473-x","volume":"17","author":"KB Mitchell","year":"2015","unstructured":"Mitchell KB, Kuerer H (2015) Ductal carcinoma in situ: treatment update and current trends. Curr Oncol Rep 17:48. https:\/\/doi.org\/10.1007\/s11912-015-0473-x","journal-title":"Curr Oncol Rep"},{"key":"7621_CR2","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1245\/s10434-023-13370-1","volume":"30","author":"AL Nash","year":"2023","unstructured":"Nash AL, Hwang ES (2023) The landmark series\u2014ductal carcinoma in situ: the evolution of treatment. Ann Surg Oncol 30:3206\u20133214. https:\/\/doi.org\/10.1245\/s10434-023-13370-1","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7621_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16(2):441\u2013452. https:\/\/doi.org\/10.1200\/JCO.1998.16.2.441","journal-title":"J Clin Oncol"},{"issue":"9169","key":"7621_CR4","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. The Lancet 353(9169):1993\u20132000. https:\/\/doi.org\/10.1016\/S0140-6736(99)05036-9","journal-title":"The Lancet"},{"issue":"32","key":"7621_CR5","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"10","author":"F W\u00e4rnberg","year":"2014","unstructured":"W\u00e4rnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, Ringberg A, Karlsson P, Arnesson LG, Anderson H, Jirstr\u00f6m K, Holmberg L (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J Clin Oncol 10(32):3613\u20133618. https:\/\/doi.org\/10.1200\/JCO.2014.56.2595","journal-title":"J Clin Oncol"},{"issue":"9203","key":"7621_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/s0140-6736(99)06341-2","volume":"355","author":"JP Julien","year":"2000","unstructured":"Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. The Lancet 355(9203):528\u2013533. https:\/\/doi.org\/10.1016\/s0140-6736(99)06341-2","journal-title":"The Lancet"},{"issue":"1","key":"7621_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE, Elis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: longterm results from UK\/ANZ DCIS trial. Lancet Oncol 12(1):21\u201329. https:\/\/doi.org\/10.1016\/S1470-2045(10)70266-7","journal-title":"Lancet Oncol"},{"issue":"32","key":"7621_CR8","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1200\/JCO.21.01083","volume":"39","author":"B McCormick","year":"2021","unstructured":"McCormick B, Winter KA, Woodward W, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O\u2019Rourke MA, Walker EM, Strom EA, Hopkins JO, Pierce LJ, Pu AT, Sumida KNM, Vesprini D, Moughan J, White JR (2021) Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG Oncology\/RTOG 9804. J Clin Oncol 39(32):3574\u20133582. https:\/\/doi.org\/10.1200\/JCO.21.01083","journal-title":"J Clin Oncol"},{"issue":"6","key":"7621_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103(6):478\u2013488. https:\/\/doi.org\/10.1093\/jnci\/djr027","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"7621_CR10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ejso.2016.05.024","volume":"42","author":"Mammary Fold Academic Research Collaborative","year":"2016","unstructured":"Mammary Fold Academic Research Collaborative (2016) Variation in the management of ductal carcinoma in situ in the UK: results of the mammary fold national practice survey. Eur J Surg Oncol 42(8):1153\u20131161","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"7621_CR11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/curroncol28020130","volume":"28","author":"R Seguin","year":"2021","unstructured":"Seguin R, Peiris L (2021) National variations in the work-up, investigation, and surgical management of ductal carcinoma in situ of the breast across Canadian surgeons. Curr Oncol 28(2):1366\u20131375","journal-title":"Curr Oncol"},{"issue":"6","key":"7621_CR12","first-page":"446","volume":"29","author":"SA Kaufman","year":"2015","unstructured":"Kaufman SA, Harris EE, Bailey L et al (2015) ACR appropriateness criteria\u00ae ductal carcinoma in situ. Oncology 29(6):446\u2013458","journal-title":"Oncology"},{"issue":"2","key":"7621_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijrobp.2018.09.022","volume":"103","author":"SN Hamilton","year":"2019","unstructured":"Hamilton SN, Nichol A, Wai E, Gondara L, Vel\u00e1squez Garc\u00eda HA, Speers C, Diocee R, Truong P (2019) Local relapse after breast-conserving therapy versus mastectomy for extensive pure ductal carcinoma in situ \u22654 cm. Int J Radiat Oncol Biol Phys 103(2):381\u2013388. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.09.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7621_CR14","unstructured":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology (NCCN Guidelines\u00ae) for breast cancer, version 6.2024"},{"issue":"33","key":"7621_CR15","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","volume":"34","author":"M Morrow","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS (2016) Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. J Clin Oncol 34(33):4040\u20134046. https:\/\/doi.org\/10.1200\/JCO.2016.68.3573","journal-title":"J Clin Oncol"},{"key":"7621_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076022","volume":"383","author":"RSJM Schmitz","year":"2023","unstructured":"Schmitz RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, Cresta C, Timbres J, Liu YH, Byng D, Lynch T, Menegaz BA, Collyar D, Hyslop T, Thomas S, Love JK, Schaapveld M, Bhattacharjee P, Ryser MD, Sawyer E, Hwang ES, Thompson A, Wesseling J, Lips EH, Schmidt MK, Grand Challenge PRECISION consortium (2023) Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study. BMJ 383:e076022. https:\/\/doi.org\/10.1136\/bmj-2023-076022","journal-title":"BMJ"},{"issue":"1","key":"7621_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10549-021-06488-x","volume":"192","author":"D Rodin","year":"2022","unstructured":"Rodin D, Sutradhar R, Nofech-Mozes S, Gu S, Faught N, Hahn E, Fong C, Trebinjac S, Paszat L, Rakovitch E (2022) Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy. Breast Cancer Res Treat 192(1):223\u2013233. https:\/\/doi.org\/10.1007\/s10549-021-06488-x","journal-title":"Breast Cancer Res Treat"},{"key":"7621_CR18","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1245\/s10434-023-13472-w","volume":"30","author":"JF Ryan","year":"2023","unstructured":"Ryan JF, Lesniak DM, Cordeiro E et al (2023) Surgeon factors influencing breast surgery outcomes: a scoping review to define the modern breast surgical oncologist. Ann Surg Oncol 30:4695\u20134713. https:\/\/doi.org\/10.1245\/s10434-023-13472-w","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7621_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clon.2009.02.001","volume":"21","author":"A Munshi","year":"2009","unstructured":"Munshi A, Kakkar S, Bhutani R, Jalali R, Budrukkar A, Dinshaw KA (2009) Factors influencing cosmetic outcome in breast conservation. Clin Oncol (R Coll Radiol) 21(4):285\u2013293. https:\/\/doi.org\/10.1016\/j.clon.2009.02.001","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"7621_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3747\/co.26.4305","volume":"26","author":"E Dicks","year":"2019","unstructured":"Dicks E, Roome R, Chafe J, Powell E, McCrate F, Simmonds C, Etchegary H (2019) Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives. Curr Oncol 26(2):216\u2013225. https:\/\/doi.org\/10.3747\/co.26.4305","journal-title":"Curr Oncol"},{"issue":"12","key":"7621_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, Pijnappel RM, Bijker N, Rutgers EJ, Wesseling J (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ\u2014the LORD study. Eur J Cancer 51(12):1497\u20131510. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.008","journal-title":"Eur J Cancer"},{"key":"7621_CR22","doi-asserted-by":"publisher","first-page":"113276","DOI":"10.1016\/j.ejca.2023.113276","volume":"192","author":"RSJM Schmitz","year":"2023","unstructured":"Schmitz RSJM, Engelhardt EG, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager J, Griffioen R, Ret\u00e8l V, Bijker N, Mann RM, van Duijnhoven F, Wesseling J, Bleiker EMA, Grand Challenge PRECISION Consortium (2023) Active surveillance versus treatment in low-risk DCIS: women\u2019s preferences in the LORD-trial. Eur J Cancer 192:113276. https:\/\/doi.org\/10.1016\/j.ejca.2023.113276","journal-title":"Eur J Cancer"},{"issue":"16","key":"7621_CR23","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51(16):2296\u20132303. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.017","journal-title":"Eur J Cancer"},{"issue":"3","key":"7621_CR24","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T, Frank E, Pinto D, Basila D, Collyar D, Bennett A, Kaplan C, Rosenberg S, Thompson A, Weiss A, Partridge A (2019) The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9(3):e026797. https:\/\/doi.org\/10.1136\/bmjopen-2018-026797","journal-title":"BMJ Open"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07621-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07621-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07621-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:06:37Z","timestamp":1743386797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07621-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7621"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07621-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}